BioXcel Therapeutics Company

BioXcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence.
Technology: Artificial Intelligence, Biotechnology, Health Care
Industry: AI, Drug Repurposing, End-to-end Drug Development, United States
Headquarters: Branford, Connecticut, United States
Founded Date: 2017-01-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 2
Total Funding: 140000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-04-19
Last Funding Type: Post-IPO Debt

Visit Website
Register and Claim Ownership